Web News Insider
-
Could the Moderna-Merck Melanoma Vaccine Win FDA Approval Within Two Years? What We Know
Intismeran met primary endpoints in phase 3, but FDA filing date remains unannounced as companies race toward potential 2027 approval.
-
BMS RYZ101 Meets Phase 3 Goal in Neuroendocrine Tumors After Lutetium-177 Failure
Bristol Myers Squibb reports its actinium-225 therapy met primary endpoint in ACTION-1 trial, offering hope for a narrow group of patients.
-
Epitalon Peptide Shows Mixed Results in Lab Studies on Telomeres and Cancer
While a viral reel claims Epitalon reversed aging, lab data shows it extends telomeres in healthy cells but also activates dangerous pathways…
-
Why Retirees Must Shift Emergency Fund Strategies Beyond Standard Three-Month Rules
Retirees face unique spending shocks like home repairs and medical costs, requiring a shift from salary-based savings to portfolio-based liquidity buffers.
-
How New Immunotherapy Aims to Break the Cycle of Surgery for RRP Patients
The FDA has approved VOCERYQ, a novel DNA-based immunotherapy designed to reduce the need for repeated surgical interventions in adults with RRP.
-
BioSapien Begins First-in-Human MediChip Trial for Rectal Cancer at Burjeel
Abu Dhabi startup BioSapien doses first patient in Phase I trial evaluating its biodegradable MediChip implant to deliver localized chemotherapy directly to…
-
FDA Approves Tirzepatide to Reduce Heart Attack Risk in Type 2 Diabetes
The FDA has approved tirzepatide (Mounjaro) for cardiovascular risk reduction, marking a shift from glucose-only control to comprehensive heart protection based on…
-
UK Trial Aims to Cut Breast Cancer Radiotherapy from Three Weeks to Five Days
Government-funded FAST-Forward Boost trial recruits 1,000 patients across 39 hospitals to test shorter treatment with targeted boost dose.
-
Waters and Labcorp partner to expand FDA-approved HPV testing options by late 2026
Diagnostic leaders aim to reshape cervical cancer screening availability through a nationwide network offering comprehensive genotyping via clinician-collected and at-home samples.
-
Hospital Beds for Critically Ill Kids Vanish as Costs Rise
Nationwide closures of pediatric units convert beds to adult care, forcing families to travel hours for lifesaving treatment.
-
Why Personal Bankruptcies Jumped 11% Despite Economic Growth
Rising credit costs and eroded savings are driving more Americans to bankruptcy even as GDP expands and unemployment remains low.
-
RFK Jr. Orders FDA to Allow Unapproved Peptide Injections
Health Secretary Robert F. Kennedy Jr. orders the FDA to halt enforcement on six unapproved wellness peptides, prompting safety concerns from scientists…
-
How Lendmark Financial Services Is Expanding Access to Credit in Local Markets
As Lendmark Financial Services grows its branch network across the Southeast, here is how the lender is shaping personal finance options for…
-
New Study Shows Tucatinib Delays Progression in Breast Cancer Spread to Brain
A Duke-led trial found adding tucatinib to standard care substantially delayed worsening in HER2-positive breast cancer patients with new brain metastases.
-
FDA Draft Guidance Would Let Individualized Gene Editing Variants Share One License Application
New regulatory framework aims to streamline submissions for multiple gene therapy variants under a single application, addressing critical gaps in oversight for…
-
GSK to Nearly Double Cancer Drugs in Trials as It Rebuilds Oncology Ahead of HIV Patent Cliff
Amidst looming patent expirations for HIV blockbusters, GSK is aggressively expanding its oncology pipeline, aiming to double late-stage cancer drug studies by…
-
Four in 10 US Adults Carry Health Care Debt as Michigan Wipes Another $21 Million
Learn how insured patients can navigate hospital billing departments, leverage legal protections, and manage unexpected medical debt.
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
Court rulings on liability and funding disputes force patients to wait years for verdicts, while Medicare recovery rules threaten to consume settlement…
-
How Private Credit Facilities Expand Access to Affordable Consumer Lending
Examining how institutional credit partnerships like Viola Credit’s latest deal influence the personal finance landscape and fair lending availability.
-
Stanford Digital Twins Point to a Drug Pair That May Delay Preterm Labor
Researchers use immune system simulations to find a drug pair that delays labor 15 times better than aspirin alone, offering hope for…
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
MSI-H status identifies rectal cancer patients who may avoid surgery via dostarlimab, a new FDA-approved immunotherapy targeting defective DNA repair.
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
A smooth protein surface and high GTP affinity stymied drugmakers until a cysteine at G12C enabled covalent inhibitors like divarasib.
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
Phase 1 trial of OSK gene therapy in three glaucoma patients finds no serious side effects and preliminary visual field improvements at…
-
Fulvic Acid and Cancer: What the 14-Hour Melanoma Study Actually Found
A viral reel cites a 2022 lab study on melanoma cells. Here is what it tested, what it found and what it…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992